VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 57 filers reported holding VYNE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $247,591 | -32.7% | 1,650,607 | +0.1% | 0.00% | – |
| Q3 2022 | $368,000 | -47.4% | 1,649,489 | -8.4% | 0.00% | – |
| Q2 2022 | $700,000 | -27.2% | 1,800,530 | +21.7% | 0.00% | – |
| Q1 2022 | $962,000 | -58.0% | 1,479,926 | -34.1% | 0.00% | – |
| Q4 2021 | $2,290,000 | -32.4% | 2,246,231 | -7.8% | 0.00% | – |
| Q3 2021 | $3,386,000 | -60.4% | 2,436,432 | 0.0% | 0.00% | – |
| Q2 2021 | $8,552,000 | -49.8% | 2,436,432 | -2.1% | 0.00% | – |
| Q1 2021 | $17,039,000 | – | 2,489,261 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 400,000 | $2,738,000 | 6.10% |
| DSC Advisors, L.P. | 1,038,145 | $7,106,000 | 4.40% |
| CM Management, LLC | 143,750 | $984,000 | 0.73% |
| Perceptive Advisors | 6,773,954 | $46,368,000 | 0.59% |
| DELTEC ASSET MANAGEMENT LLC | 441,491 | $3,022,000 | 0.45% |
| Perennial Investment Advisors, LLC | 35,000 | $240,000 | 0.10% |
| Tekla Capital Management LLC | 135,395 | $927,000 | 0.03% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 10,051 | $69,000 | 0.02% |
| AXA S.A. | 882,124 | $6,038,000 | 0.02% |
| STALEY CAPITAL ADVISERS INC | 25,000 | $171,000 | 0.01% |